ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/06/26 | 2,330 | 2,355 | 2,308 | 2,346 | +16 | +0.7% | 60,300 |
2018/06/25 | 2,349 | 2,354 | 2,320 | 2,330 | -15 | -0.6% | 89,200 |
2018/06/22 | 2,357 | 2,369 | 2,307 | 2,345 | -12 | -0.5% | 190,600 |
2018/06/21 | 2,355 | 2,384 | 2,327 | 2,357 | +2 | +0.1% | 112,500 |
2018/06/20 | 2,383 | 2,400 | 2,346 | 2,355 | -25 | -1.1% | 104,000 |
2018/06/19 | 2,409 | 2,430 | 2,375 | 2,380 | -8 | -0.3% | 121,400 |
2018/06/18 | 2,389 | 2,478 | 2,340 | 2,388 | +93 | +4.1% | 254,600 |
2018/06/15 | 2,284 | 2,321 | 2,278 | 2,295 | +15 | +0.7% | 100,300 |
2018/06/14 | 2,302 | 2,302 | 2,269 | 2,280 | -31 | -1.3% | 42,600 |
2018/06/13 | 2,285 | 2,329 | 2,285 | 2,311 | +33 | +1.4% | 45,800 |
2018/06/12 | 2,270 | 2,294 | 2,267 | 2,278 | +4 | +0.2% | 30,300 |
2018/06/11 | 2,269 | 2,282 | 2,240 | 2,274 | +12 | +0.5% | 43,900 |
2018/06/08 | 2,259 | 2,286 | 2,253 | 2,262 | -13 | -0.6% | 82,100 |
2018/06/07 | 2,320 | 2,320 | 2,268 | 2,275 | -33 | -1.4% | 51,900 |
2018/06/06 | 2,258 | 2,316 | 2,254 | 2,308 | ±0 | ±0% | 48,000 |
2018/06/05 | 2,282 | 2,310 | 2,274 | 2,308 | +17 | +0.7% | 33,800 |
2018/06/04 | 2,295 | 2,300 | 2,275 | 2,291 | +14 | +0.6% | 52,500 |
2018/06/01 | 2,242 | 2,289 | 2,234 | 2,277 | +33 | +1.5% | 56,900 |
2018/05/31 | 2,226 | 2,250 | 2,203 | 2,244 | +18 | +0.8% | 74,900 |
2018/05/30 | 2,251 | 2,255 | 2,225 | 2,226 | -56 | -2.5% | 42,500 |
2018/05/29 | 2,275 | 2,294 | 2,260 | 2,282 | +7 | +0.3% | 31,600 |
2018/05/28 | 2,322 | 2,322 | 2,263 | 2,275 | -36 | -1.6% | 44,100 |
2018/05/25 | 2,296 | 2,339 | 2,296 | 2,311 | -30 | -1.3% | 55,600 |
2018/05/24 | 2,293 | 2,355 | 2,293 | 2,341 | +56 | +2.5% | 73,400 |
2018/05/23 | 2,272 | 2,299 | 2,272 | 2,285 | +17 | +0.7% | 58,400 |
2018/05/22 | 2,294 | 2,304 | 2,265 | 2,268 | -48 | -2.1% | 71,400 |
2018/05/21 | 2,333 | 2,348 | 2,307 | 2,316 | -27 | -1.2% | 44,200 |
2018/05/18 | 2,369 | 2,373 | 2,340 | 2,343 | -26 | -1.1% | 55,600 |
2018/05/17 | 2,380 | 2,396 | 2,365 | 2,369 | -5 | -0.2% | 50,300 |
2018/05/16 | 2,348 | 2,387 | 2,340 | 2,374 | +25 | +1.1% | 90,100 |
2018/05/15 | 2,342 | 2,355 | 2,328 | 2,349 | +18 | +0.8% | 92,300 |
2018/05/14 | 2,271 | 2,347 | 2,258 | 2,331 | -17 | -0.7% | 120,600 |
2018/05/11 | 2,320 | 2,348 | 2,314 | 2,348 | +22 | +0.9% | 83,200 |
2018/05/10 | 2,285 | 2,341 | 2,279 | 2,326 | +57 | +2.5% | 92,500 |
2018/05/09 | 2,307 | 2,310 | 2,251 | 2,269 | -38 | -1.6% | 64,400 |
2018/05/08 | 2,250 | 2,309 | 2,230 | 2,307 | +74 | +3.3% | 126,200 |
2018/05/07 | 2,236 | 2,239 | 2,200 | 2,233 | +2 | +0.1% | 38,900 |
2018/05/02 | 2,240 | 2,240 | 2,199 | 2,231 | -8 | -0.4% | 30,900 |
2018/05/01 | 2,251 | 2,251 | 2,228 | 2,239 | -10 | -0.4% | 34,300 |
2018/04/27 | 2,248 | 2,261 | 2,230 | 2,249 | +18 | +0.8% | 63,600 |
2018/04/26 | 2,216 | 2,235 | 2,192 | 2,231 | +10 | +0.5% | 55,000 |
2018/04/25 | 2,200 | 2,241 | 2,198 | 2,221 | +8 | +0.4% | 96,900 |
2018/04/24 | 2,200 | 2,220 | 2,185 | 2,213 | +19 | +0.9% | 87,200 |
2018/04/23 | 2,200 | 2,202 | 2,178 | 2,194 | +2 | +0.1% | 28,300 |
2018/04/20 | 2,181 | 2,203 | 2,181 | 2,192 | +1 | ±0% | 44,100 |
2018/04/19 | 2,198 | 2,203 | 2,170 | 2,191 | -11 | -0.5% | 59,300 |
2018/04/18 | 2,194 | 2,208 | 2,183 | 2,202 | +8 | +0.4% | 48,500 |
2018/04/17 | 2,200 | 2,207 | 2,185 | 2,194 | +6 | +0.3% | 45,500 |
2018/04/16 | 2,155 | 2,191 | 2,137 | 2,188 | +53 | +2.5% | 43,600 |
2018/04/13 | 2,176 | 2,182 | 2,123 | 2,135 | -30 | -1.4% | 62,800 |
1751~
1800
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム